Nexalin Technology- Warrants (15/09/2025) EBIT

The latest EBIT for NXLIW is $-8.4M as of March 2026. That compares with $-8.7M in the prior-year period — up 3.0% year over year. That is above the sector sector average of $-77M. Investors often review this figure alongside Nexalin Technology- Warrants (15/09/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NXLIW's EBIT moved from $-8.7M to $-8.4M — a 3.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nexalin Technology- Warrants (15/09/2025)'s operating scale or balance-sheet position.

Against its sector companies, NXLIW currently prints $-8.4M for EBIT, while the sector average sits near $-77M. That is roughly 89.0% above the sector mean. Large gaps often invite a closer look at Nexalin Technology- Warrants (15/09/2025)'s growth, margins, and balance sheet.

A EBIT figure of $-8.4M for NXLIW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-77M. Explore the charts below for those layers of context.

After noting NXLIW's EBIT ($-8.4M), review year-over-year change from $-8.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.